This paperwork
is approved on an emergency basis under the following conditions:
1) In the future, FDA will not distribute instructions for
paperwork submission as part of a guidance document without first
consulting the OMB. 2) FDA will detach the application instruction
from the main guidance document. 3) FDA will revise the application
instructions to contain the PRA mandated disclosure statement
including the collection's OMB number, expiration date and expected
burden. 4) FDA will add the following language to the application
instruction: "FDA will accept electronic submissions from any
applicant that wishes to submit in this format." 5) FDA will
provide a copy of the final draft before commencing the
collection.
Inventory as of this Action
Requested
Previously Approved
11/30/2003
11/30/2003
25
0
0
2,550
0
0
0
0
0
Information from this collection will
be used by FDA to implement an Inspection by Accredited Persons
program that will train and accredit persons that wish to conduct
inspections of eligible manufacturers of class II and class III
medical devices. This action is required by MDUFMA.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.